TRPX Stock Price, News & Analysis

TRPX NASDAQ

Company Description

TRPX (NASDAQ: TRPX) is a publicly traded biotechnology company in the Health Technology sector.

TRPX stock has declined 87.2% over the past year.

This page provides a comprehensive overview of TRPX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-87.22%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

TRPX (TRPX) stock. Over the past 12 months, the stock has lost 87.2%.

Latest News

View All

August 21, 2020

—

Therapix Biosciences Announces Replacement of its Board of Directors

management

July 9, 2020

—

Therapix Biosciences Announces OTC Pink Ticker Symbol 'TRPXY' and Removal of Injunction by Israeli Court

July 1, 2020

-48.90%

Therapix Biosciences Receives Notice of Delisting and Injunction from Israeli Court

June 29, 2020

-15.92%

Therapix Biosciences Raises $2.6 Million in Private Placement

private placement

TRPX has 4 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include management, private placement. View all TRPX news →

SEC Filings

View All

No SEC filings available for TRPX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

TRPX Company Profile & Sector Positioning

TRPX (TRPX) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the NASDAQ.